Plasmapheresis in neuroleptic malignant syndrome

L. Gaitini; M. Fradis; S. Vaida; S. Krimerman; A. Beny

doi:10.1111/j.1365-2044.1997.11-az011.x

Plasmapheresis in neuroleptic malignant syndrome

L. Gaitini, M. Fradis, S. Vaida, S. Krimerman, A. Beny

Research output: Contribution to journal › Article › peer-review

10 Scopus citations

Abstract

Neuroleptic malignant syndrome is a severe and potentially fatal reaction to neuroleptic drugs. Treatment requires withdrawal of the neuroleptic agent, metabolic and cardiovascular support, physical cooling and treatment with dantrolene sodium and bromcriptine mesylate. We report a therapeutic success of plasmapheresis in a case of neuroleptic malignant syndrome in which conventional therapy had failed. We postulate that plasmapheresis may prove to be a useful tool in treating this frequently fatal disease.

Original language	English (US)
Pages (from-to)	165-168
Number of pages	4
Journal	Anaesthesia
Volume	52
Issue number	2
DOIs	https://doi.org/10.1111/j.1365-2044.1997.11-az011.x
State	Published - 1997

All Science Journal Classification (ASJC) codes

Anesthesiology and Pain Medicine

Access to Document

10.1111/j.1365-2044.1997.11-az011.x

Cite this

@article{5c0881d4fdda49d38a496283726527e6,

title = "Plasmapheresis in neuroleptic malignant syndrome",

abstract = "Neuroleptic malignant syndrome is a severe and potentially fatal reaction to neuroleptic drugs. Treatment requires withdrawal of the neuroleptic agent, metabolic and cardiovascular support, physical cooling and treatment with dantrolene sodium and bromcriptine mesylate. We report a therapeutic success of plasmapheresis in a case of neuroleptic malignant syndrome in which conventional therapy had failed. We postulate that plasmapheresis may prove to be a useful tool in treating this frequently fatal disease.",

author = "L. Gaitini and M. Fradis and S. Vaida and S. Krimerman and A. Beny",

year = "1997",

doi = "10.1111/j.1365-2044.1997.11-az011.x",

language = "English (US)",

volume = "52",

pages = "165--168",

journal = "Anaesthesia",

issn = "0003-2409",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "2",

}

TY - JOUR

T1 - Plasmapheresis in neuroleptic malignant syndrome

AU - Gaitini, L.

AU - Fradis, M.

AU - Vaida, S.

AU - Krimerman, S.

AU - Beny, A.

PY - 1997

Y1 - 1997

N2 - Neuroleptic malignant syndrome is a severe and potentially fatal reaction to neuroleptic drugs. Treatment requires withdrawal of the neuroleptic agent, metabolic and cardiovascular support, physical cooling and treatment with dantrolene sodium and bromcriptine mesylate. We report a therapeutic success of plasmapheresis in a case of neuroleptic malignant syndrome in which conventional therapy had failed. We postulate that plasmapheresis may prove to be a useful tool in treating this frequently fatal disease.

AB - Neuroleptic malignant syndrome is a severe and potentially fatal reaction to neuroleptic drugs. Treatment requires withdrawal of the neuroleptic agent, metabolic and cardiovascular support, physical cooling and treatment with dantrolene sodium and bromcriptine mesylate. We report a therapeutic success of plasmapheresis in a case of neuroleptic malignant syndrome in which conventional therapy had failed. We postulate that plasmapheresis may prove to be a useful tool in treating this frequently fatal disease.

UR - http://www.scopus.com/inward/record.url?scp=0031040446&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031040446&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2044.1997.11-az011.x

DO - 10.1111/j.1365-2044.1997.11-az011.x

M3 - Article

C2 - 9059103

AN - SCOPUS:0031040446

SN - 0003-2409

VL - 52

SP - 165

EP - 168

JO - Anaesthesia

JF - Anaesthesia

IS - 2

ER -

Plasmapheresis in neuroleptic malignant syndrome

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Cite this